T-group (topology)
2007.1.5 ATC-like
Ligands and drugs
1,989
Member domains
318
with ligand contacts (≤ 4 Å)
16.0% of members
303
with DrugDomain annotations
15.2% of members
250
with a DrugBank compound
12.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 2007.1.5 belongs to X-group 2007 Flavodoxin-like, which binds 8.9 ligand superclasses per 20 proteins, broader than 77% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02517 | DGL | D-Glutamic Acid | 106 |
| DB00139 | SIN | Succinic acid | 16 |
| DB00142 | GLU | Glutamic acid | 12 |
| DB09110 | COM | Coenzyme M | 12 |
| DB01735 | C2N | 3-Chloroalaninate | 8 |
| DB08698 | VGA | 1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL | 8 |
| DB03345 | BME | Mercaptoethanol | 7 |
| DB00128 | ASP | Aspartic acid | 6 |
| DB02210 | HEZ | Hexane-1,6-Diol | 6 |
| DB02655 | DAS | D-Aspartic Acid | 6 |
| DB09459 | TLA | L-tartaric acid | 5 |
| DB03309 | NHE | N-cyclohexyltaurine | 4 |
| DB04299 | MAE | Maleic acid | 4 |
| DB07937 | I24 | 2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine | 4 |
| DB01673 | UMA | Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine | 2 |
| DB02174 | DGN | D-Glutamine | 2 |
| DB04313 | ACB | (3S)-3-methyl-D-aspartic acid | 2 |
| DB04538 | 2AS | threo-3-methyl-L-aspartic acid | 2 |
| DB08272 | NHL | (4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID | 2 |
| DB09269 | PAC | Phenylacetic acid | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| DGL | D-GLUTAMIC ACID | 114 |
| 9S8 | Non-cubane [4Fe-4S]-cluster | 40 |
| CL | CHLORIDE ION | 38 |
| CAmetal | CALCIUM ION | 17 |
| SIN | SUCCINIC ACID | 16 |
| COM | 1-THIOETHANESULFONIC ACID | 12 |
| GLU | GLUTAMIC ACID | 12 |
| Kmetal | POTASSIUM ION | 9 |
| C2N | 3-chloro-D-alanine | 8 |
| VGA | 1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL | 8 |
| BME | BETA-MERCAPTOETHANOL | 7 |
| HEZ | HEXANE-1,6-DIOL | 7 |
| ASP | ASPARTIC ACID | 6 |
| DAS | D-ASPARTIC ACID | 6 |
| 003 | 5-METHYL-7-(2-METHYLPROPYL)-2-(NAPHTHALEN-1-YLMETHYL)-3-PYRIDIN-4-YL-2H-PYRAZOLO[3,4-D]PYRIMIDINE-4,6(5H,7H)-DIONE | 4 |
| 2AL | 1-(2,5-DIOXO-2,5-DIHYDRO-1H-IMIDAZOL-4-YL)UREA | 4 |
| 5HY | [(4R)-2,5-dioxoimidazolidin-4-yl]acetic acid | 4 |
| 9SB | 2-bromanylethanesulfonic acid | 4 |
| I24 | 2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine | 4 |
| KRH | 5-methyl-3-(1-methyl-1H-imidazol-5-yl)-7-(2-methylpropyl)-2-(naphthalen-1-ylmethyl)-2H-pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione | 4 |